LIVE — 21:01 ET
Top Strategies #1 SMR Build Out 481.2% #2 AI Cooling Power Infra 335.8% #3 Quantum Compute Pure Play 459.2% #4 Silicon Photonics Optical 384.6% #5 Core Satellite 255.4% #6 Momentum 218.6% #7 AI Mega Ecosystem (Combined) 247.3% #8 Concentrate Winners 177.6% All strategies →
BETAExperimental layout — view production →
ASKMELON ARTICLES

Ulta Beauty Beat With 5.3% Comps — Then Guided the Rest of the Year to Half That

Ulta Beauty did the hard thing a retailer is supposed to do: it beat. First-quarter fiscal 2026 net sales rose 11.1% to roughly $3.16 billion, comparable sales climbed 5.3%, operating income grew 11.6% to $448.3 million, and diluted earnings per share jumped 15.5% to $7.74 — all ahead of Wall Street, and management nudged its profit outlook higher. The stock is rich, the loyalty program is enormous, the balance sheet is clean. And yet buried inside the same press release that produced the beat is a number the celebration skips past: for the full fiscal year, Ulta reaffirmed comparable-sales guidance of just 2.5% to 3.5% — less than half the pace it just posted. Management is telling you, in its own filing, that the quarter you are applauding is not the run-rate. This is a piece about the gap between a beat and a guide, about an operating margin that has fallen from roughly 16% at its 2022 peak toward 12%, about competitors moving onto Ulta's turf as its biggest distribution experiment winds down, and about a stock priced for a category that already had its boom.

· ← All articles

There is a particular kind of earnings report that is more dangerous than a miss, and Ulta Beauty just filed one. A miss is honest. A miss tells investors something is wrong, the stock corrects, and the conversation moves to what gets fixed. A beat-and-reaffirm is subtler. On June 2, 2026, Ulta reported a first quarter for the period ended May 2 that cleared every bar the Street had set: net sales up 11.1% to about $3.16 billion, comparable sales up 5.3% against a StreetAccount estimate near 4.6%, operating income up 11.6% to $448.3 million, diluted EPS up 15.5% to $7.74. Management raised the low end of its full-year operating-income growth guidance and lifted the EPS range. The headline writers did their job; the stock got its applause.

But read the guidance line, not the headline. For all of fiscal 2026, Ulta still expects comparable sales to grow only 2.5% to 3.5%. It posted 5.3% in the first quarter and left the full-year number untouched. There is only one arithmetic that reconciles those two facts: the company is forecasting that comparable-sales growth over the remaining three quarters slows materially — to something in the low single digits, possibly toward the low end of that range, to drag a 5.3% start down to a 2.5%-to-3.5% finish. That is not a bearish analyst's projection. That is Ulta's own outlook, reaffirmed on the day of the beat. The forensic question is simple: when a market prices a stock for re-acceleration and the company guides for deceleration, who is right — the spreadsheet or the people who run the stores?

The beat and the guide are telling two different stories

Begin with the mechanics of the 5.3% comp, because they matter to whether it persists. Ulta disclosed that the comparable-sales increase came from a 3.7% rise in average ticket and a 1.6% rise in transactions. That mix is worth sitting with. The larger contributor — by more than two to one — was people spending more per visit, not more people visiting. Average ticket is the lever most exposed to pricing, mix, and the lapping of prior promotions; transactions are the cleaner read on whether the franchise is genuinely pulling in incremental customers. A comp built mostly on ticket is a comp that depends on the consumer continuing to trade up and absorb price. It is a more fragile foundation than one built on traffic, and it is precisely the kind of foundation that erodes first when discretionary budgets tighten.

Now layer the guide on top. Management is not naive about its own business. When a company that just printed 5.3% chooses not to raise its full-year comp guidance — chooses to leave 2.5% to 3.5% in place — it is making a statement about the back half. Either it sees the comparison base getting harder, or it sees the ticket-driven strength as partly transient, or it is simply being conservative. Conservatism is a virtue; but for an investor paying a premium multiple, the relevant fact is that the company is explicitly declining to underwrite the run-rate the market is celebrating. The beat is the past. The guide is the future. They disagree, and the stock is priced as if only the beat exists.

A category that already had its boom

To understand why deceleration is the base case and not the bear case, widen the lens to the category. The years after the pandemic were extraordinary for beauty. Cosmetics, fragrance, and skincare went through a demand surge as consumers re-emerged, "lipstick effect" spending returned, and prestige and mass beauty both ran hot. Ulta rode that wave with comps that, at the peak of the recovery, ran double digits. Those were not normal years; they were a release of pent-up demand layered on top of price inflation. The danger in extrapolating any retailer's results off a boom is that the boom becomes the implicit baseline, and every subsequent year that merely normalizes gets read as a disappointment relative to a number that was never sustainable.

Ulta's own trajectory tells the normalization story without editorializing. Comparable sales decelerated from the post-pandemic highs to 5.4% for full fiscal 2025, and the company's guide calls for 2.5% to 3.5% in fiscal 2026 — a step down again. That is the signature of a category returning to its long-run cadence, which for beauty retail in a mature U.S. market is low-single-digit organic growth plus square-footage expansion. There is nothing wrong with that business. It is a fine, cash-generative, defensible business. The problem is the valuation attached to it. A stock priced for re-acceleration is a stock priced for the boom to come back. The company's guidance says the boom is not coming back; it says the new normal is low single digits. Cyclical normalization is being asked to behave like secular growth, and the multiple is the bill for the difference.

The margin came off a peak the bulls quietly forgot

The most underappreciated number in the Ulta story is not the comp — it is the operating margin, and the direction it has traveled. At the height of the post-pandemic surge, Ulta's operating margin reached roughly 16% on a full-year basis, an extraordinary level for a specialty retailer and one that reflected a perfect storm of strong demand, light promotion, and operating leverage on a fixed cost base. That margin was the engine of the earnings growth that justified the stock's premium. And it has been receding ever since.

Walk the staircase down. Operating margin compressed from that mid-teens peak through fiscal 2023 and fiscal 2024, and for full fiscal 2025 operating income landed at roughly $1.5 billion, or about 12.4% of net sales. That is a decline of several full percentage points of margin from the peak — and in a business with Ulta's revenue base, every point of operating margin is hundreds of millions of dollars of profit. The company has been candid about the drivers: gross-margin deleverage from store occupancy and supply-chain costs, the cost of strategic investments, wage and salon expense, and the normalization of promotions and merchandise margin as the demand surge faded. The first-quarter fiscal 2026 gross margin did improve year over year — to 40.1% from 39.1%, helped by lower inventory shrink and better merchandise margin — which is genuine and good. But the full-year picture is one of a margin structure that sits well below its peak and that management guides to grow operating income only 6.5% to 9% on net sales growth of 6% to 7% — meaning margin is roughly flat to modestly up, not racing back to 16%.

Here is why that matters for the multiple. When margin is expanding, earnings grow faster than sales, and a premium P/E can be defended by the idea that operating leverage will keep compounding. When margin has already peaked and is now hovering several points below it, earnings growth converges toward sales growth — low single digits to mid single digits — and the leverage argument inverts. The bull case implicitly assumes the margin engine still has gears left. The reported trajectory says the engine downshifted years ago.

The Target experiment is winding down, not scaling up

For several years, one of the cleanest growth narratives attached to Ulta was its shop-in-shop partnership with Target — "Ulta Beauty at Target" — which placed curated Ulta assortments inside Target stores and on Target's site, extending Ulta's prestige-beauty reach into a mass-market footprint it could never have built on its own. The bull thesis treated this as optionality: a low-capital channel that could scale to hundreds of additional points of distribution and capture a customer who shops Target but not a standalone Ulta. It was, for a while, exactly the kind of asymmetric growth lever that justifies paying up.

That lever is no longer the growth story it was. The partnership has matured rather than expanded into the open-ended ramp some models assumed, and the incremental contribution from net new shop-in-shop doors is a fraction of what the early narrative implied. The forensic point is not that the Target relationship failed — it is that a story the market once priced as expanding optionality has quietly become a steady-state contributor at best. When a growth lever flattens, the burden of producing the comp shifts entirely back to the core box: the standalone Ulta store and its digital channel, in a U.S. beauty market that is fully penetrated and increasingly contested. The partnership that was supposed to be incremental is now just part of the run-rate the company itself guides to 2.5%-to-3.5% comps.

Sephora moved onto the lawn

While Ulta's distribution optionality flattened, its single most important competitor built a mirror-image network inside another mass retailer. Sephora's partnership with Kohl's put hundreds of Sephora shops inside Kohl's stores across the country, targeting precisely the suburban, value-conscious, prestige-curious customer that Ulta's own Target tie-up was meant to capture. The structural result is that the two leading beauty specialists now both have a mass-retail distribution arm — and they are fishing in overlapping ponds. The differentiation that once let Ulta own the "prestige-meets-mass, all in one store" position is no longer unique.

This is the part of the bear case that does not show up in a single quarter's comp and is easy to wave away during a beat. Share competition is slow. It does not announce itself with a bad print; it shows up as a comp that runs a point or two lower than it otherwise would have, year after year, as a rival captures the marginal customer and the marginal launch. Ulta's transaction growth in the first quarter was 1.6% — positive, but modest, and the smaller half of the comp. In a category growing low single digits, with a well-capitalized competitor expanding its own distribution and prestige brands increasingly willing to sell direct and through multiple channels, the question is whether Ulta's traffic can keep growing at all without leaning ever harder on ticket and promotion. The competitive map has shifted under the franchise, and the premium multiple assumes it hasn't.

Brand access is a borrowed moat

Part of what made Ulta special was access — the breadth of brands, from mass drugstore lines to prestige houses, under one roof, which gave the consumer a reason to choose Ulta over a single-brand boutique or a mass retailer's limited beauty aisle. But access is a moat only as long as the brands need the distributor more than the distributor needs them. That balance has been shifting across consumer retail for a decade, and beauty is no exception. The hottest brands increasingly build their own direct-to-consumer machines, court multiple retail partners to avoid dependence on any one, and treat exclusivity as a bargaining chip rather than a permanent arrangement.

When a fast-growing prestige or indie brand can reach the consumer through its own site, through Sephora, through Amazon, and through a mass partner, the retailer's leverage to demand favorable terms — exclusives, margin, launch windows — erodes. Ulta has managed these relationships well, and its scale still makes it a must-have partner for most brands. But "must-have" is a weaker position than "only-have," and the trend in beauty distribution is toward more doors, not fewer. A moat built on being the place brands have to go is worth less when brands have somewhere else to go. The model's gross margin — which depends in part on the terms Ulta can extract — is exposed to exactly this slow erosion of bargaining power, and the long, gentle slide in operating margin from the peak is at least partly the sound of that bargaining power normalizing.

The denominator problem in same-store sales

There is a structural subtlety in how Ulta — like every store-based retailer — reports growth that flatters the appearance of health, and it deserves naming. Headline net-sales growth of 11.1% sounds like a company accelerating. But that figure blends comparable-store sales (the organic, like-for-like measure) with the contribution of new stores opened over the past year and the shop-in-shop footprint. The honest organic measure is the comp: 5.3% in the quarter, and 2.5% to 3.5% guided for the year. The gap between the 11.1% headline and the 5.3% comp is, substantially, square footage — growth you buy with capital by opening boxes, not growth the existing base generates.

This is the denominator illusion that runs through all of retail. As long as a chain keeps opening stores, total revenue keeps climbing, and the income statement looks like it is compounding. But unit growth is finite — there are only so many viable U.S. locations for a beauty superstore — and each new store cannibalizes some of the trade area of existing ones. Eventually the new-store contribution shrinks, the comp becomes the whole story, and the comp is the number the company guides to the low single digits. An investor paying a growth multiple should be underwriting the organic comp, not the capital-fueled headline. On the organic measure, by the company's own forecast, Ulta is a low-single-digit grower. The 11.1% is real, but it is partly bought, and bought growth does not deserve the multiple of earned growth.

What you are actually paying for

Put a price on it. In late May 2026, ahead of the print, Ulta traded around $509 a share, against a trailing P/E in the low-to-mid 20s. Management's fiscal 2026 EPS guidance of $28.36 to $28.80 implies double-digit EPS growth — but that growth leans heavily on buybacks shrinking the share count and on the margin holding, not on a re-acceleration in the underlying comp. A low-single-digit organic grower with a peaked-and-receded margin, a flattening distribution lever, and a major competitor expanding onto its turf is not obviously a low-20s-P/E business. It is plausibly a mid-teens-multiple business — a high-quality, cash-generative specialty retailer trading like one, not a compounder trading like a secular grower.

The asymmetry is the point. To justify the current multiple, Ulta has to keep beating and, eventually, to raise that 2.5%-to-3.5% full-year comp guide toward the 5% it just printed — it has to convince the market that the beat is the run-rate after all. If instead the company's own guidance proves right and comps settle into the low single digits while margin stays off its peak, the earnings growth converges to something pedestrian and the multiple has nowhere to go but down. You are paying a premium for re-acceleration in a business the company is guiding to decelerate. When the upside requires the company to be wrong about itself and the downside only requires it to be right, the risk-reward is not on the buyer's side.

What the bulls genuinely get right

Now the other side, fairly and specifically, because the bull case on Ulta is not a strawman — it is strong, and an honest forensic piece has to concede where it is strong.

Start with the obvious: Ulta beat, and not narrowly. A 5.3% comp against a ~4.6% estimate, 11.1% sales growth, 11.6% operating-income growth, and 15.5% EPS growth is a genuinely good quarter by any retail standard, and it came with raised profit guidance. A company in secular decline does not print that. The traffic component was positive — transactions up 1.6% — which means the franchise is still pulling in incremental customers, not just squeezing existing ones. Gross margin expanded year over year on lower shrink and better merchandise margin, which is real operational execution, not financial engineering.

The loyalty program is the crown jewel, and the bears underweight it. Ulta's rewards membership numbers in the tens of millions of active members and captures the overwhelming majority of the company's sales, giving it a first-party data asset and a repeat-purchase engine that most retailers would trade their balance sheets for. That program is a structural moat that does not erode in a quarter, and it is the reason Ulta's traffic has proven more durable than skeptics expected through multiple consumer cycles. The services business — salon, brow, skin — adds a reason to visit that pure e-commerce and shop-in-shop rivals cannot easily replicate, and it pulls product attachment with it.

The balance sheet is clean, the company generates substantial free cash flow, and management has been an aggressive, consistent buyer of its own stock, shrinking the share count and compounding EPS even when comps are modest. A low-single-digit comp plus margin stability plus buybacks can still produce low-double-digit EPS growth — which is exactly what fiscal 2026 guidance implies. And on competition: Ulta has faced the "Sephora is coming" narrative for years and has kept growing through it; the U.S. beauty market has expanded enough to support more than one winner, and Ulta's scale, store base, and loyalty data give it real defenses. If the consumer stays healthy and beauty keeps outgrowing the broader retail category — as it has — then a low-20s multiple on a best-in-class operator with a fortress loyalty program is not absurd. It is a quality business, and quality businesses command premiums for a reason. The bear case here is about price and pace, not about a broken company.

The reflexivity of a premium multiple

One more frame, because it governs how this resolves. A premium multiple is not just a valuation; it is a standing dare. It dares the company to keep beating, because the day it merely meets — the day a quarter is fine rather than spectacular, the day a comp comes in at the low end of guidance instead of three points above the estimate — the multiple has no cushion. Ulta has set itself exactly this trap by guiding the full year well below the quarter it just delivered. If the back half of fiscal 2026 simply matches the company's own guidance, that will arithmetically mean comps slowing sharply from the 5.3% start, and the market will have to decide whether to keep paying for re-acceleration into the teeth of decelerating prints.

This is how priced-for-perfection stocks unwind: not in a crash but in a slow re-rating, quarter by quarter, as the gap between the celebrated beat and the guided run-rate finally closes — downward, toward the guide, rather than upward, toward the beat. The company has told you which way it expects the gap to close. The forensic discipline is to believe the guidance over the applause, and to notice that the very report everyone called a triumph contained, in plain text, the case for caution.

The kicker

Ulta is a fine company — clean balance sheet, a loyalty engine tens of millions strong, real services differentiation, and a management team that just beat and raised. None of that is in dispute, and an honest skeptic concedes all of it. What is in dispute is the price, and the price is the one variable the company cannot manage for you. The market is paying a premium built on the 5.3% comp Ulta just posted; Ulta's own full-year guidance says the rest of the year runs at 2.5% to 3.5%, less than half that pace, while the operating margin sits several points below its 2022 peak, the Target distribution lever has flattened, and Sephora keeps expanding onto the same suburban lawn. The bull needs the beat to be the future. Management is guiding for the beat to be the past.

When a company beats by three points and then guides the rest of the year to half of what it just printed, the most important number in the press release is not the one in the headline — it is the one the headline forgot to mention.

Disclaimer

This article is produced for informational and educational purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. All data cited reflects information available as of the publication time noted above. Market conditions may change materially between publication and when you read this. Past performance of any strategy referenced is not indicative of future results. Consult a qualified financial advisor before making investment decisions.

Related reading
FEATURE

e.l.f. Beauty's Sales Jumped 35%, but Strip Out the Acquisition and Growth Was 1%

Related tickers — live prices:

FEATURE

Estée Lauder priced at 26x forward earnings on a 2% organic turn it can't yet bank

Estée Lauder told a triumphant story on May 1, 2026: organic sales back to growth, China gaining share, Hainan accelerating, fragrance running double-digit, guidance raised. The tape rewarded it — the…

FEATURE

Williams-Sonoma trades at 25 times earnings on a housing market that won't move

Williams-Sonoma just posted the kind of quarter that home-furnishings retailers were not supposed to be able to post in 2026: comparable brand revenue up 4.8%, a 44.0% gross margin, $1.93 in diluted e…

FEATURE

Five Below's 22.7% Comp Laps a Collapse, and Its Own Guidance Cuts It to 8% Next Quarter

Five Below delivered the kind of quarter that turnaround stories are built on: net sales up 32.5% to $1.29 billion, comparable sales up 22.7%, adjusted earnings per share up 158%, and full-year guidan…